APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Anti-Infective Medications

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global OTC Anti-Infective Medications Industry Growth and Trends Forecast to 2032

2 January 2026102 pages

Choose your research edition.

Industry ResearchOTC Anti-Infective Medications Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Anti-Infective Medications Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal OTC Anti-Infective Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Anti-Infective Medications Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Anti-Infective Medications Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

According to APO Research, the global OTC Anti-Infective Medications market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for OTC Anti-Infective Medications is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for OTC Anti-Infective Medications is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Anti-Infective Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the OTC Anti-Infective Medications market include Abbott, Sanofi, Novartis, Merck, Roche, Pfizer, GlaxoSmithKline, Optimer Pharmaceuticals and Novabay Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global OTC Anti-Infective Medications market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The OTC Anti-Infective Medications market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global OTC Anti-Infective Medications market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to OTC Anti-Infective Medications.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global OTC Anti-Infective Medications market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

OTC Anti-Infective Medications Market by Company

Abbott

Sanofi

Novartis

Merck

Roche

Pfizer

GlaxoSmithKline

Optimer Pharmaceuticals

Novabay Pharmaceuticals

NanoViricides

MerLion Pharma

Bristol-Myers Squibb

Basilea Pharmaceutica

OTC Anti-Infective Medications Segment by Type

Antiseptic

Antiparasitics

Antifungals

OTC Anti-Infective Medications Segment by Application

E-Commerce

Drug Stores

Hospital Pharmacies

OTC Anti-Infective Medications Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Anti-Infective Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Anti-Infective Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Anti-Infective Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of OTC Anti-Infective Medications companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global OTC Anti-Infective Medications Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global OTC Anti-Infective Medications Market Size by Region (2021-2026) & (US$ Million) Table 3. Global OTC Anti-Infective Medications Market Share by Region (2021-2026) Table 4. Global OTC Anti-Infective Medications Market Size by Region (2027-2032) & (US$ Million) Table 5. Global OTC Anti-Infective Medications Market Share by Region (2027-2032) Table 6. Global OTC Anti-Infective Medications Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global OTC Anti-Infective Medications Market Size by Type (2021-2026) & (US$ Million) Table 8. Global OTC Anti-Infective Medications Market Size Share by Type (2021-2026) Table 9. Global OTC Anti-Infective Medications Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global OTC Anti-Infective Medications Market Size Share Forecasted by Type (2027-2032) Table 11. North America OTC Anti-Infective Medications Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America OTC Anti-Infective Medications Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe OTC Anti-Infective Medications Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe OTC Anti-Infective Medications Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific OTC Anti-Infective Medications Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific OTC Anti-Infective Medications Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America OTC Anti-Infective Medications Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America OTC Anti-Infective Medications Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa OTC Anti-Infective Medications Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa OTC Anti-Infective Medications Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global OTC Anti-Infective Medications Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global OTC Anti-Infective Medications Market Size by Application (2021-2026) & (US$ Million) Table 23. Global OTC Anti-Infective Medications Market Size Share by Application (2021-2026) Table 24. Global OTC Anti-Infective Medications Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global OTC Anti-Infective Medications Market Size Share Forecasted by Application (2027-2032) Table 26. North America OTC Anti-Infective Medications Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America OTC Anti-Infective Medications Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe OTC Anti-Infective Medications Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe OTC Anti-Infective Medications Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific OTC Anti-Infective Medications Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific OTC Anti-Infective Medications Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America OTC Anti-Infective Medications Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America OTC Anti-Infective Medications Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa OTC Anti-Infective Medications Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa OTC Anti-Infective Medications Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. OTC Anti-Infective Medications Industry Trends Table 37. OTC Anti-Infective Medications Industry Drivers Table 38. OTC Anti-Infective Medications Industry Opportunities and Challenges Table 39. OTC Anti-Infective Medications Industry Restraints Table 40. Global OTC Anti-Infective Medications Revenue by Company (US$ Million) & (2021-2026) Table 41. Global OTC Anti-Infective Medications Revenue Market Share by Company (2021-2026) Table 42. Global OTC Anti-Infective Medications Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global OTC Anti-Infective Medications Key Company Headquarters & Area Served Table 44. Global OTC Anti-Infective Medications Company, Product Type & Application Table 45. Global OTC Anti-Infective Medications Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global OTC Anti-Infective Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Abbott Company Information Table 49. Abbott Business Overview Table 50. Abbott OTC Anti-Infective Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Abbott OTC Anti-Infective Medications Product Portfolio Table 52. Abbott Recent Development Table 53. Sanofi Company Information Table 54. Sanofi Business Overview Table 55. Sanofi OTC Anti-Infective Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Sanofi OTC Anti-Infective Medications Product Portfolio Table 57. Sanofi Recent Development Table 58. Novartis Company Information Table 59. Novartis Business Overview Table 60. Novartis OTC Anti-Infective Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Novartis OTC Anti-Infective Medications Product Portfolio Table 62. Novartis Recent Development Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck OTC Anti-Infective Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Merck OTC Anti-Infective Medications Product Portfolio Table 67. Merck Recent Development Table 68. Roche Company Information Table 69. Roche Business Overview Table 70. Roche OTC Anti-Infective Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Roche OTC Anti-Infective Medications Product Portfolio Table 72. Roche Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer OTC Anti-Infective Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Pfizer OTC Anti-Infective Medications Product Portfolio Table 77. Pfizer Recent Development Table 78. GlaxoSmithKline Company Information Table 79. GlaxoSmithKline Business Overview Table 80. GlaxoSmithKline OTC Anti-Infective Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. GlaxoSmithKline OTC Anti-Infective Medications Product Portfolio Table 82. GlaxoSmithKline Recent Development Table 83. Optimer Pharmaceuticals Company Information Table 84. Optimer Pharmaceuticals Business Overview Table 85. Optimer Pharmaceuticals OTC Anti-Infective Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Optimer Pharmaceuticals OTC Anti-Infective Medications Product Portfolio Table 87. Optimer Pharmaceuticals Recent Development Table 88. Novabay Pharmaceuticals Company Information Table 89. Novabay Pharmaceuticals Business Overview Table 90. Novabay Pharmaceuticals OTC Anti-Infective Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Novabay Pharmaceuticals OTC Anti-Infective Medications Product Portfolio Table 92. Novabay Pharmaceuticals Recent Development Table 93. NanoViricides Company Information Table 94. NanoViricides Business Overview Table 95. NanoViricides OTC Anti-Infective Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. NanoViricides OTC Anti-Infective Medications Product Portfolio Table 97. NanoViricides Recent Development Table 98. MerLion Pharma Company Information Table 99. MerLion Pharma Business Overview Table 100. MerLion Pharma OTC Anti-Infective Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. MerLion Pharma OTC Anti-Infective Medications Product Portfolio Table 102. MerLion Pharma Recent Development Table 103. Bristol-Myers Squibb Company Information Table 104. Bristol-Myers Squibb Business Overview Table 105. Bristol-Myers Squibb OTC Anti-Infective Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Bristol-Myers Squibb OTC Anti-Infective Medications Product Portfolio Table 107. Bristol-Myers Squibb Recent Development Table 108. Basilea Pharmaceutica Company Information Table 109. Basilea Pharmaceutica Business Overview Table 110. Basilea Pharmaceutica OTC Anti-Infective Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Basilea Pharmaceutica OTC Anti-Infective Medications Product Portfolio Table 112. Basilea Pharmaceutica Recent Development Table 113. North America OTC Anti-Infective Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America OTC Anti-Infective Medications Market Size by Country (2021-2026) & (US$ Million) Table 115. North America OTC Anti-Infective Medications Market Share by Country (2021-2026) Table 116. North America OTC Anti-Infective Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America OTC Anti-Infective Medications Market Share Forecast by Country (2027-2032) Table 118. Europe OTC Anti-Infective Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe OTC Anti-Infective Medications Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe OTC Anti-Infective Medications Market Share by Country (2021-2026) Table 121. Europe OTC Anti-Infective Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe OTC Anti-Infective Medications Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific OTC Anti-Infective Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific OTC Anti-Infective Medications Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific OTC Anti-Infective Medications Market Share by Country (2021-2026) Table 126. Asia-Pacific OTC Anti-Infective Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific OTC Anti-Infective Medications Market Share Forecast by Country (2027-2032) Table 128. Latin America OTC Anti-Infective Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Latin America OTC Anti-Infective Medications Market Size by Country (2021-2026) & (US$ Million) Table 130. Latin America OTC Anti-Infective Medications Market Share by Country (2021-2026) Table 131. Latin America OTC Anti-Infective Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Latin America OTC Anti-Infective Medications Market Share Forecast by Country (2027-2032) Table 133. Middle East & Africa OTC Anti-Infective Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2021-2026) & (US$ Million) Table 135. Middle East & Africa OTC Anti-Infective Medications Market Share by Country (2021-2026) Table 136. Middle East & Africa OTC Anti-Infective Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Middle East & Africa OTC Anti-Infective Medications Market Share Forecast by Country (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. OTC Anti-Infective Medications Product Image Figure 3. Global OTC Anti-Infective Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global OTC Anti-Infective Medications Market Size (2021-2032) & (US$ Million) Figure 5. Global OTC Anti-Infective Medications Market Share by Region: 2025 VS 2032 Figure 6. Global OTC Anti-Infective Medications Market Share by Region (2021-2032) Figure 7. North America OTC Anti-Infective Medications Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe OTC Anti-Infective Medications Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific OTC Anti-Infective Medications Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America OTC Anti-Infective Medications Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa OTC Anti-Infective Medications Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Antiseptic Image Figure 13. Global Antiseptic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Antiparasitics Image Figure 15. Global Antiparasitics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Antifungals Image Figure 17. Global Antifungals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global OTC Anti-Infective Medications Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global OTC Anti-Infective Medications Market Share by Type 2025 VS 2032 Figure 20. North America OTC Anti-Infective Medications Market Size Share by Type (2021-2032) Figure 21. Europe OTC Anti-Infective Medications Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific OTC Anti-Infective Medications Market Size Share by Type (2021-2032) Figure 23. Latin America OTC Anti-Infective Medications Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa OTC Anti-Infective Medications Market Size Share by Type (2021-2032) Figure 25. E-Commerce Image Figure 26. Global E-Commerce Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Drug Stores Image Figure 28. Global Drug Stores Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Hospital Pharmacies Image Figure 30. Global Hospital Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global OTC Anti-Infective Medications Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global OTC Anti-Infective Medications Market Share by Application 2025 VS 2032 Figure 33. North America OTC Anti-Infective Medications Market Size Share by Application (2021-2032) Figure 34. Europe OTC Anti-Infective Medications Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific OTC Anti-Infective Medications Market Size Share by Application (2021-2032) Figure 36. Latin America OTC Anti-Infective Medications Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa OTC Anti-Infective Medications Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 OTC Anti-Infective Medications Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America OTC Anti-Infective Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America OTC Anti-Infective Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America OTC Anti-Infective Medications Market Share by Country (2021-2032) Figure 43. Europe OTC Anti-Infective Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe OTC Anti-Infective Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe OTC Anti-Infective Medications Market Share by Country (2021-2032) Figure 46. Asia-Pacific OTC Anti-Infective Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific OTC Anti-Infective Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific OTC Anti-Infective Medications Market Share by Country (2021-2032) Figure 49. Latin America OTC Anti-Infective Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America OTC Anti-Infective Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America OTC Anti-Infective Medications Market Share by Country (2021-2032) Figure 52. Middle East & Africa OTC Anti-Infective Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa OTC Anti-Infective Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa OTC Anti-Infective Medications Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Antiseptic
  • Antiparasitics
  • Antifungals
Applications
  • E-Commerce
  • Drug Stores
  • Hospital Pharmacies
Companies covered
  • Abbott
  • Sanofi
  • Novartis
  • Merck
  • Roche
  • Pfizer
  • GlaxoSmithKline
  • Optimer Pharmaceuticals
  • Novabay Pharmaceuticals
  • NanoViricides
  • MerLion Pharma
  • Bristol-Myers Squibb
  • Basilea Pharmaceutica

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global OTC Anti-Infective Medications Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global OTC Anti-Infective Medications Market Size by Region (2021-2032)
  5. 1.4.1 Global OTC Anti-Infective Medications Market Size by Region (2021-2026)
  6. 1.4.2 Global OTC Anti-Infective Medications Market Size by Region (2027-2032)
  7. 1.5 Key Regions OTC Anti-Infective Medications Market Size (2021-2032)
  8. 1.5.1 North America OTC Anti-Infective Medications Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe OTC Anti-Infective Medications Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific OTC Anti-Infective Medications Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America OTC Anti-Infective Medications Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa OTC Anti-Infective Medications Market Size Growth Rate (2021-2032)
2 OTC Anti-Infective Medications Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Antiseptic
  3. 2.1.2 Antiparasitics
  4. 2.1.3 Antifungals
  5. 2.2 Global OTC Anti-Infective Medications Market Size by Type
  6. 2.2.1 Global OTC Anti-Infective Medications Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global OTC Anti-Infective Medications Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global OTC Anti-Infective Medications Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global OTC Anti-Infective Medications Market Size by Regions
  10. 2.3.1 North America OTC Anti-Infective Medications Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe OTC Anti-Infective Medications Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific OTC Anti-Infective Medications Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America OTC Anti-Infective Medications Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa OTC Anti-Infective Medications Market Size Breakdown by Type (2021-2026)
3 OTC Anti-Infective Medications Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 E-Commerce
  3. 3.1.2 Drug Stores
  4. 3.1.3 Hospital Pharmacies
  5. 3.2 Global OTC Anti-Infective Medications Market Size by Application
  6. 3.2.1 Global OTC Anti-Infective Medications Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global OTC Anti-Infective Medications Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global OTC Anti-Infective Medications Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global OTC Anti-Infective Medications Market Size by Regions
  10. 3.3.1 North America OTC Anti-Infective Medications Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe OTC Anti-Infective Medications Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific OTC Anti-Infective Medications Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America OTC Anti-Infective Medications Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa OTC Anti-Infective Medications Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 OTC Anti-Infective Medications Industry Trends
  2. 4.2 OTC Anti-Infective Medications Industry Drivers
  3. 4.3 OTC Anti-Infective Medications Industry Opportunities and Challenges
  4. 4.4 OTC Anti-Infective Medications Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by OTC Anti-Infective Medications Revenue (2021-2026)
  2. 5.2 Global OTC Anti-Infective Medications Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global OTC Anti-Infective Medications Key Company Headquarters & Area Served
  4. 5.4 Global OTC Anti-Infective Medications Company, Product Type & Application
  5. 5.5 Global OTC Anti-Infective Medications Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global OTC Anti-Infective Medications Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 OTC Anti-Infective Medications Players Market Share by Revenue in 2025
  9. 5.6.3 2025 OTC Anti-Infective Medications Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott OTC Anti-Infective Medications Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Abbott OTC Anti-Infective Medications Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi OTC Anti-Infective Medications Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi OTC Anti-Infective Medications Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis OTC Anti-Infective Medications Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Novartis OTC Anti-Infective Medications Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck OTC Anti-Infective Medications Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Merck OTC Anti-Infective Medications Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Roche
  26. 6.5.1 Roche Company Information
  27. 6.5.2 Roche Business Overview
  28. 6.5.3 Roche OTC Anti-Infective Medications Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Roche OTC Anti-Infective Medications Product Portfolio
  30. 6.5.5 Roche Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer OTC Anti-Infective Medications Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer OTC Anti-Infective Medications Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline OTC Anti-Infective Medications Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline OTC Anti-Infective Medications Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 Optimer Pharmaceuticals
  44. 6.8.1 Optimer Pharmaceuticals Company Information
  45. 6.8.2 Optimer Pharmaceuticals Business Overview
  46. 6.8.3 Optimer Pharmaceuticals OTC Anti-Infective Medications Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Optimer Pharmaceuticals OTC Anti-Infective Medications Product Portfolio
  48. 6.8.5 Optimer Pharmaceuticals Recent Developments
  49. 6.9 Novabay Pharmaceuticals
  50. 6.9.1 Novabay Pharmaceuticals Company Information
  51. 6.9.2 Novabay Pharmaceuticals Business Overview
  52. 6.9.3 Novabay Pharmaceuticals OTC Anti-Infective Medications Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Novabay Pharmaceuticals OTC Anti-Infective Medications Product Portfolio
  54. 6.9.5 Novabay Pharmaceuticals Recent Developments
  55. 6.10 NanoViricides
  56. 6.10.1 NanoViricides Company Information
  57. 6.10.2 NanoViricides Business Overview
  58. 6.10.3 NanoViricides OTC Anti-Infective Medications Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 NanoViricides OTC Anti-Infective Medications Product Portfolio
  60. 6.10.5 NanoViricides Recent Developments
  61. 6.11 MerLion Pharma
  62. 6.11.1 MerLion Pharma Company Information
  63. 6.11.2 MerLion Pharma Business Overview
  64. 6.11.3 MerLion Pharma OTC Anti-Infective Medications Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 MerLion Pharma OTC Anti-Infective Medications Product Portfolio
  66. 6.11.5 MerLion Pharma Recent Developments
  67. 6.12 Bristol-Myers Squibb
  68. 6.12.1 Bristol-Myers Squibb Company Information
  69. 6.12.2 Bristol-Myers Squibb Business Overview
  70. 6.12.3 Bristol-Myers Squibb OTC Anti-Infective Medications Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Bristol-Myers Squibb OTC Anti-Infective Medications Product Portfolio
  72. 6.12.5 Bristol-Myers Squibb Recent Developments
  73. 6.13 Basilea Pharmaceutica
  74. 6.13.1 Basilea Pharmaceutica Company Information
  75. 6.13.2 Basilea Pharmaceutica Business Overview
  76. 6.13.3 Basilea Pharmaceutica OTC Anti-Infective Medications Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Basilea Pharmaceutica OTC Anti-Infective Medications Product Portfolio
  78. 6.13.5 Basilea Pharmaceutica Recent Developments
7 North America
  1. 7.1 North America OTC Anti-Infective Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America OTC Anti-Infective Medications Market Size by Country (2021-2026)
  3. 7.3 North America OTC Anti-Infective Medications Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe OTC Anti-Infective Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe OTC Anti-Infective Medications Market Size by Country (2021-2026)
  3. 8.3 Europe OTC Anti-Infective Medications Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific OTC Anti-Infective Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific OTC Anti-Infective Medications Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific OTC Anti-Infective Medications Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America OTC Anti-Infective Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America OTC Anti-Infective Medications Market Size by Country (2021-2026)
  3. 10.3 South America OTC Anti-Infective Medications Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa OTC Anti-Infective Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa OTC Anti-Infective Medications Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst